Recall Register

Food, drugs, devices › Golden State Medical Supply Inc.

Drug recall: Atenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by: GSMS, Incorp

FDA enforcement event 90909 · Class I · initiated 29 Sep 2022 · status Terminated · terminated 20 Mar 2025

DrugVoluntary: Firm initiated1 product recordCamarillo, CA

Golden State Medical Supply Inc. (Camarillo, CA) initiated this drug recall on 29 Sep 2022; FDA lists 1 product record under event 90909, classified Class I.

FDA defines Class I as a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. 18% of the 325 drug enforcement events initiated in 2022 carry the same class.

Status: Terminated, terminated 20 Mar 2025. Initiation: voluntary: firm initiated. Golden State Medical Supply Inc. has 32 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Golden State Medical Supply Inc., Camarillo, CA.

Reason for recall

"Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets"

Distribution

"USA Nationwide"

Product records

Recall numberProductQuantityClassStatusReport date
D-0019-2023Atenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC 60429-027-102,584 BottlesClass ITerminated2 Nov 2022

Context

18%of 2022 drug events are Class I325 events that year
1product record in this eventfirm median: 1
32events on this register for the firm

Other enforcement events for Golden State Medical Supply Inc.

InitiatedProduct (first record)TypeClassRecords
21 Aug 2026Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, DrugClass II1
7 Aug 2026Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-DrugClass II1
29 May 2026GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban PhDrugClass II1
27 Apr 2026Primidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, IncoDrugClass III2
26 Nov 2025Baclofen Tablets USP, 10 mg, 1000-count bottles, Rx only, Marketed by: GSMS, Incorporated, CA 93012 USA. NDC 51407-973-1DrugClass II1
20 Oct 2025NIACIN Extended-Release Tablets, USP, 1,000 mg, 90 tablets per bottle, Rx only, Manufactured by: Kremers Urban PharmaceuDrugClass II1
5 Mar 2025PRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA 93012 NDC 51407-444-3DrugClass II1
13 May 2024Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, a) 30 capsules bottles, NDC 60429-165-30; b) 90 capsules bottleDrugClass II1
14 Feb 2024Fluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 g net fill, Rx only, Manufactured by: ADrugClass II1
12 Jan 2024Budesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA, UPDrugClass II1

All 32 events for Golden State Medical Supply Inc.

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets"

What does Class I mean?

FDA classifies recalls by relative degree of health hazard. Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

Where was the product distributed?

FDA's distribution pattern field reads: "USA Nationwide"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 20 Mar 2025. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.